Screener
Nuvation Bio NUVB Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Nuvation Bio’s reported figures.
Based on the most recent quarter.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
FAQ
- What is Nuvation Bio's debt-to-equity?
- Nuvation Bio (NUVB) reported debt-to-equity of 0× in Q2 2026.
- How has Nuvation Bio's debt-to-equity changed year-over-year?
- Nuvation Bio's debt-to-equity decreased by 75.8% year-over-year, from 0.2× to 0×.
- What is the long-term trend for Nuvation Bio's debt-to-equity?
- Over 5 years (2020 to 2025), Nuvation Bio's debt-to-equity has grown at a 57.9% compound annual growth rate (CAGR), from 0× to 0.2×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Nuvation Bio's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude